Related Experiment Video

Updated: Oct 16, 2026

Analysis of Cell Cycle Position in Mammalian Cells
12:19

Analysis of Cell Cycle Position in Mammalian Cells

Published on: January 21, 2012

Inducible pRb2/p130 expression and growth-suppressive mechanisms: evidence of a pRb2/p130, p27Kip1, and cyclin E

C M Howard1, P P Claudio, A De Luca

  • 1Department of Pathology, Anatomy & Cell Biology, Jefferson Medical College, Philadelphia, Pennsylvania 19107, USA.

Cancer Research
|May 29, 2000
PubMed

Insights

The retinoblastoma protein pRb2/p130 suppresses tumor growth by inhibiting cell cycle kinases and increasing p27Kip1 levels. This protein interacts with p27Kip1 and influences its binding to JCV TAg.

Area of Science:

  • Molecular Biology
  • Cell Cycle Regulation
  • Oncology

Background:

  • The retinoblastoma protein family (pRb/p105, p107, pRb2/p130) regulates cell cycle progression.
  • These proteins control G1-S checkpoint through overlapping pathways.
  • JC virus T-antigen (JCV TAg) oncoprotein drives neoplastic transformation.

Purpose of the Study:

  • To investigate the in vivo molecular mechanisms of pRb2/p130's growth-suppressive function.
  • To understand how pRb2/p130 overcomes JCV TAg-mediated transformation.
  • To elucidate the interplay between pRb2/p130, p27Kip1, and cell cycle regulators.

Main Methods:

  • Utilized a tetracycline-regulated gene expression system to control RB2/p130 expression in JCV-induced hamster brain tumor cells.
  • Assessed in vivo effects on cyclin-associated kinase activity, protein levels, and transcription factors.
  • Investigated protein-protein interactions using co-immunoprecipitation.

Main Results:

  • pRb2/p130 induction inhibited cyclin A- and cyclin E-associated kinase activity.
  • pRb2/p130 increased p27Kip1 levels, likely by inhibiting proteolysis.
  • pRb2/p130 decreased cyclin A and E2F-1 while increasing cyclin E; its growth suppression correlated with E2F-binding capacity.
  • pRb2/p130 and p27Kip1 are JCV TAg targets and interact independently of TAg.
  • pRb2/p130 negatively modulated p27Kip1 binding to JCV TAg.

Conclusions:

  • pRb2/p130 elicits growth suppression by inhibiting key cell cycle kinases and stabilizing p27Kip1.
  • pRb2/p130 and p27Kip1 may cooperate in regulating proliferation.
  • A negative feedback loop involving pRb2/p130, p27Kip1, and cyclin E may exist.

More Related Videos

Inducible and Reversible Dominant-negative (DN) Protein Inhibition08:35

Inducible and Reversible Dominant-negative (DN) Protein Inhibition

Published on: January 7, 2019

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...